A
Alexandre R.R. Pery
Researcher at VU University Amsterdam
Publications - 80
Citations - 2307
Alexandre R.R. Pery is an academic researcher from VU University Amsterdam. The author has contributed to research in topics: Population & Chironomus riparius. The author has an hindex of 28, co-authored 79 publications receiving 2086 citations.
Papers
More filters
Journal ArticleDOI
Fluoxetine effects assessment on the life cycle of aquatic invertebrates.
Alexandre R.R. Pery,Marion Gust,Bernard Vollat,Raphaël Mons,Maria Ramil,Guido Fink,Thomas Ternes,Jeanne Garric +7 more
TL;DR: General mechanistic energy-based models showed poor relevance for data analysis, which suggests that fluoxetine targets specific mechanisms of reproduction.
Journal ArticleDOI
A modeling approach to link food availability, growth, emergence, and reproduction for the midge Chironomus riparius
TL;DR: In this paper, the authors present models to link feeding with growth, emergence, and reproduction of the midge Chironomus riparius, which can be used in sediment risk assessment to choose feeding level and build effects models, or to predict the effects of toxicants at the population level.
Journal ArticleDOI
Effects of the parasiticide ivermectin on the cladoceran Daphnia magna and the green alga Pseudokirchneriella subcapitata
Jeanne Garric,Bernard Vollat,Karen Duis,Alexandre R.R. Pery,Thomas Junker,Maria Ramil,Guido Fink,Thomas A. Ternes +7 more
TL;DR: Toxicity of ivermectin to two freshwater organisms, the cladoceran Daphnia magna and the green alga Pseudokirchneriella subcapitata, was investigated and it is suggested that the use of this compound might pose a risk to local aquatic ecosystems.
Journal ArticleDOI
Metabolomics-on-a-chip and predictive systems toxicology in microfluidic bioartificial organs.
Laetitia Shintu,Régis Baudoin,Vincent Navratil,Jean-Matthieu Prot,Clément Pontoizeau,Marianne Defernez,Benjamin J. Blaise,Céline Domange,Alexandre R.R. Pery,Pierre Toulhoat,Cécile Legallais,Céline Brochot,Eric Leclerc,Marc-Emmanuel Dumas,Marc-Emmanuel Dumas +14 more
TL;DR: The integration of microtechnology, cell culture in microfluidic biochips, and metabolic profiling opens the development of so-called "metabolomics-on-a-chip" assays in pharmaceutical and environmental toxicology.
Journal ArticleDOI
Environmental risk assessment of human pharmaceuticals in the European Union: A case study with the β-blocker atenolol
Anette Küster,Alfredo C. Alder,Beate I. Escher,Beate I. Escher,Karen Duis,Kathrin Fenner,Kathrin Fenner,Jeanne Garric,Thomas H. Hutchinson,Thomas H. Hutchinson,David R. Lapen,Alexandre R.R. Pery,Jörg Römbke,Jason Snape,Thomas A. Ternes,Edward Topp,Anne Wehrhan,Thomas Knacker +17 more
TL;DR: The β-blocker atenolol was chosen as a case study pharmaceutical within the project ERAPharm to show acceptable risks for surface water, for groundwater, and for aquatic microorganisms and to confirm the outcome of the environmental risk assessment according to EMEA/CHMP (2006).